Glen­mark’s Con­sol­i­dated Profit Rises over 143% in Q3

The Economic Times - - Companies: Pursuit Of Profit - Our Bu­reau.

Mum­bai-based Glen­mark Phar­ma­ceu­ti­cals on Thurs­day posted ₹ 477 crore in con­sol­i­dated net profit, up 143.1% over last year, for the third quar­ter due to strong growth in the US mar­ket and its ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) busi­ness, re­ports Glen­mark had posted a con­sol­i­dated net profit of ₹ 196.2 crore in the pre­vi­ous cor­re­spond­ing quar­ter. The firm’s con­sol­i­dated rev­enue rose 42.5% to ₹ 2,535 crore dur­ing the quar­ter ended De­cem­ber 31, 2016, from ₹ 1,778.3 crore in the third quar­ter of the pre­vi­ous fis­cal, Glen­mark an­nounced on the BSE web­site.

NEW DELHI

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.